Report Detail

Pharma & Healthcare Global Drugs for Oral Mucositis Market Professional Survey Report 2019

  • RnM3766308
  • |
  • 20 September, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.

The global Drugs for Oral Mucositis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drugs for Oral Mucositis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Oral Mucositis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drugs for Oral Mucositis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drugs for Oral Mucositis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Valeant Pharmaceuticals
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma
Alliance Pharma
AMAG Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Mouthwash
Pain Control Medication
Other

Segment by Application
Hospitals
Dental Clinics
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Drugs for Oral Mucositis

      • 1.1 Definition of Drugs for Oral Mucositis
      • 1.2 Drugs for Oral Mucositis Segment by Type
        • 1.2.1 Global Drugs for Oral Mucositis Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Mouthwash
        • 1.2.3 Pain Control Medication
        • 1.2.4 Other
      • 1.3 Drugs for Oral Mucositis Segment by Applications
        • 1.3.1 Global Drugs for Oral Mucositis Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Dental Clinics
        • 1.3.4 Others
      • 1.4 Global Drugs for Oral Mucositis Overall Market
        • 1.4.1 Global Drugs for Oral Mucositis Revenue (2014-2025)
        • 1.4.2 Global Drugs for Oral Mucositis Production (2014-2025)
        • 1.4.3 North America Drugs for Oral Mucositis Status and Prospect (2014-2025)
        • 1.4.4 Europe Drugs for Oral Mucositis Status and Prospect (2014-2025)
        • 1.4.5 China Drugs for Oral Mucositis Status and Prospect (2014-2025)
        • 1.4.6 Japan Drugs for Oral Mucositis Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Drugs for Oral Mucositis Status and Prospect (2014-2025)
        • 1.4.8 India Drugs for Oral Mucositis Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Drugs for Oral Mucositis
      • 2.3 Manufacturing Process Analysis of Drugs for Oral Mucositis
      • 2.4 Industry Chain Structure of Drugs for Oral Mucositis

      3 Development and Manufacturing Plants Analysis of Drugs for Oral Mucositis

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Drugs for Oral Mucositis Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Drugs for Oral Mucositis
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Drugs for Oral Mucositis Production and Capacity Analysis
      • 4.2 Drugs for Oral Mucositis Revenue Analysis
      • 4.3 Drugs for Oral Mucositis Price Analysis
      • 4.4 Market Concentration Degree

      5 Drugs for Oral Mucositis Regional Market Analysis

      • 5.1 Drugs for Oral Mucositis Production by Regions
        • 5.1.1 Global Drugs for Oral Mucositis Production by Regions
        • 5.1.2 Global Drugs for Oral Mucositis Revenue by Regions
      • 5.2 Drugs for Oral Mucositis Consumption by Regions
      • 5.3 North America Drugs for Oral Mucositis Market Analysis
        • 5.3.1 North America Drugs for Oral Mucositis Production
        • 5.3.2 North America Drugs for Oral Mucositis Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Drugs for Oral Mucositis Import and Export
      • 5.4 Europe Drugs for Oral Mucositis Market Analysis
        • 5.4.1 Europe Drugs for Oral Mucositis Production
        • 5.4.2 Europe Drugs for Oral Mucositis Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Drugs for Oral Mucositis Import and Export
      • 5.5 China Drugs for Oral Mucositis Market Analysis
        • 5.5.1 China Drugs for Oral Mucositis Production
        • 5.5.2 China Drugs for Oral Mucositis Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Drugs for Oral Mucositis Import and Export
      • 5.6 Japan Drugs for Oral Mucositis Market Analysis
        • 5.6.1 Japan Drugs for Oral Mucositis Production
        • 5.6.2 Japan Drugs for Oral Mucositis Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Drugs for Oral Mucositis Import and Export
      • 5.7 Southeast Asia Drugs for Oral Mucositis Market Analysis
        • 5.7.1 Southeast Asia Drugs for Oral Mucositis Production
        • 5.7.2 Southeast Asia Drugs for Oral Mucositis Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Drugs for Oral Mucositis Import and Export
      • 5.8 India Drugs for Oral Mucositis Market Analysis
        • 5.8.1 India Drugs for Oral Mucositis Production
        • 5.8.2 India Drugs for Oral Mucositis Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Drugs for Oral Mucositis Import and Export

      6 Drugs for Oral Mucositis Segment Market Analysis (by Type)

      • 6.1 Global Drugs for Oral Mucositis Production by Type
      • 6.2 Global Drugs for Oral Mucositis Revenue by Type
      • 6.3 Drugs for Oral Mucositis Price by Type

      7 Drugs for Oral Mucositis Segment Market Analysis (by Application)

      • 7.1 Global Drugs for Oral Mucositis Consumption by Application
      • 7.2 Global Drugs for Oral Mucositis Consumption Market Share by Application (2014-2019)

      8 Drugs for Oral Mucositis Major Manufacturers Analysis

      • 8.1 3M Healthcare
        • 8.1.1 3M Healthcare Drugs for Oral Mucositis Production Sites and Area Served
        • 8.1.2 3M Healthcare Product Introduction, Application and Specification
        • 8.1.3 3M Healthcare Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GSK
        • 8.2.1 GSK Drugs for Oral Mucositis Production Sites and Area Served
        • 8.2.2 GSK Product Introduction, Application and Specification
        • 8.2.3 GSK Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Pfizer
        • 8.3.1 Pfizer Drugs for Oral Mucositis Production Sites and Area Served
        • 8.3.2 Pfizer Product Introduction, Application and Specification
        • 8.3.3 Pfizer Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Colgate-Palmolive
        • 8.4.1 Colgate-Palmolive Drugs for Oral Mucositis Production Sites and Area Served
        • 8.4.2 Colgate-Palmolive Product Introduction, Application and Specification
        • 8.4.3 Colgate-Palmolive Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Norgine
        • 8.5.1 Norgine Drugs for Oral Mucositis Production Sites and Area Served
        • 8.5.2 Norgine Product Introduction, Application and Specification
        • 8.5.3 Norgine Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Biovitrum
        • 8.6.1 Biovitrum Drugs for Oral Mucositis Production Sites and Area Served
        • 8.6.2 Biovitrum Product Introduction, Application and Specification
        • 8.6.3 Biovitrum Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Valeant Pharmaceuticals
        • 8.7.1 Valeant Pharmaceuticals Drugs for Oral Mucositis Production Sites and Area Served
        • 8.7.2 Valeant Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Valeant Pharmaceuticals Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 EUSA Pharma
        • 8.8.1 EUSA Pharma Drugs for Oral Mucositis Production Sites and Area Served
        • 8.8.2 EUSA Pharma Product Introduction, Application and Specification
        • 8.8.3 EUSA Pharma Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Camurus
        • 8.9.1 Camurus Drugs for Oral Mucositis Production Sites and Area Served
        • 8.9.2 Camurus Product Introduction, Application and Specification
        • 8.9.3 Camurus Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Mission Pharmacal
        • 8.10.1 Mission Pharmacal Drugs for Oral Mucositis Production Sites and Area Served
        • 8.10.2 Mission Pharmacal Product Introduction, Application and Specification
        • 8.10.3 Mission Pharmacal Drugs for Oral Mucositis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Clinigen Group
      • 8.12 Midatech Pharma
      • 8.13 Alliance Pharma
      • 8.14 AMAG Pharmaceuticals

      9 Development Trend of Analysis of Drugs for Oral Mucositis Market

      • 9.1 Global Drugs for Oral Mucositis Market Trend Analysis
        • 9.1.1 Global Drugs for Oral Mucositis Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Drugs for Oral Mucositis Regional Market Trend
        • 9.2.1 North America Drugs for Oral Mucositis Forecast 2019-2025
        • 9.2.2 Europe Drugs for Oral Mucositis Forecast 2019-2025
        • 9.2.3 China Drugs for Oral Mucositis Forecast 2019-2025
        • 9.2.4 Japan Drugs for Oral Mucositis Forecast 2019-2025
        • 9.2.5 Southeast Asia Drugs for Oral Mucositis Forecast 2019-2025
        • 9.2.6 India Drugs for Oral Mucositis Forecast 2019-2025
      • 9.3 Drugs for Oral Mucositis Market Trend (Product Type)
      • 9.4 Drugs for Oral Mucositis Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Drugs for Oral Mucositis Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Drugs for Oral Mucositis. Industry analysis & Market Report on Drugs for Oral Mucositis is a syndicated market report, published as Global Drugs for Oral Mucositis Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Drugs for Oral Mucositis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,276.00
        4,914.00
        6,552.00
        550,830.00
        826,245.00
        1,101,660.00
        292,215.00
        438,322.50
        584,430.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report